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Abstract 
Many of the products and drugs used commonly contain chemical components 
which may persist through sewage treatment works (STW) and eventually enter the aquatic 
environment as parent compounds, metabolites, or transformation products. 
Pharmaceuticals and personal care products (PPCPs) and other emerging contaminants 
(ECs) have been detected in waters (typically ng/L) as well as more recently bound to 
sediment and plastic particles (typically ng/g). Despite significant advancement of 
knowledge since the late 1990s, the fate of these contaminants/transformation products 
once introduced into the aquatic environment remains relatively unresolved.  
This review provides a unique focus on the fate of seven major groups of PPCPs/ECs 
in the aquatic environment, which is frequently not found in similar works which are often 
compound or topic-specific and limited in background knowledge. Key findings include: a) 
some replacements for regulation precluded/banned chemicals may be similarly persistent 
in the environment as those they replace, b) the adsorption of potentially bioactive 
chemicals to micro- and nanoplastics is a significant topic with risks to aquatic organisms 
potentially greater than previously thought, and c) micro-/nanoplastics are likely to remain 
of significant concern for centuries after regulatory limitations on their use become active 
due to the slow degradation of macro-plastics into smaller components.  
An interdisciplinary perspective on recent advances in the field is presented here in a 
unique way which highlights both the principle science and direction of research needed to 
elucidate the fate and transport patterns of aquatic PPCPs/ECs. Unlike similar reviews, 
which are often topic-specific, here we aim to present an overarching review of the field 
with focus on the occurrence, transformation and fate of emerging contaminants. 
Environmental presence of seven major classes of contaminants (analygesics, antibiotics, 
antineoplastics, beta-blockers, perfluorinated compounds, personal care products and 
plasticisers), factors affecting contaminant fate, association with plastic micro-
/nanoparticles and photochemical transformation are comprehensively evaluated.  
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1.0 Introduction and background of the field 
Pharmaceuticals, personal care products (PPCPs), and many other synthetic organic 
compounds have revolutionised modern life and their use is now an indispensable 
component of a healthy society.  Pharmaceutical use in particular is an integral component 
of establishing and maintaining a healthy population of both humans and livestock. In 
recent years, PPCPs and other emerging contaminants (ECs) have been detected in sewage 
effluents, surface- and ground-waters, precipitation, and occasionally drinking waters at 
trace levels (Ternes, 1998; Mohle et al., 1999; Stackelberg et al., 2004; Thomas and Hilton, 
2004; Weigel et al., 2004; Lindqvist et al., 2005; Fent et al., 2006; Jjemba et al., 2006; 
Nikolaou et al., 2007; Kasprzyk-Hordern et al., 2008; Benotti and Brownawell, 2009; 
Mahmoud et al., 2009; Silva et al., 2011; Lopez-Serna et al., 2013; Tijani et al., 2016). 
Furthermore, these compounds are also shown to be present in suspended solids and river 
sediment (McClellan and Halden, 2010; Walters et al., 2010; Silva et al., 2011; Wilkinson et 
al., 2017).  
The seemingly ubiquitous environmental presence of pharmaceuticals and other so-
called ‘emerging contaminants’, albeit in trace or ultra-trace (below ng/L) concentrations, 
has become of great concern in recent years (Tijani et al., 2016). Furthermore, the extent of 
PPCPs and other ECs found in the environment, as well as their often largely unknown 
transformation products, is virtually limitless as new drugs and replacements for regulatory 
limited compounds are continually being introduced to market. 
 Many pharmaceuticals and personal care products contain complex chemical 
structures, often in combination. The original source of these products can be traced to 
respective manufacturing plants (e.g., 3303 tonnes of paracetamol were produced in France 
in 2008). However, after leaving manufacturing plants, their routes of environmental 
exposure become more complex, less understood, and differ between urban and rural 
environments (Figure 1). Every human represents a source of PPCP and other emerging 
contamination, particularly with increasing use of pharmaceuticals (Table 2). From use of 
soaps and plastics to prescription and non-prescription pharmaceuticals, the personal care 
products and pharmaceuticals we use in everyday life will inevitably enter the environment 
after use and excretion. Un-used pharmaceuticals, disposed of in toilets or drains, as well as 
partially or un-metabolised medication excretions by humans have been shown to be a 
significant source of prescription and non-prescription drug contamination, representing up 
to 90% of input (National Association of Clean Water Agencies, 2012). Olsen et al. (2009) 
found urine to be the most significant source of PPCP elimination in humans. 
Pharmaceuticals are often not completely metabolised in the body resulting in some 
proportion of the parent compound (or conjugated derivative) entering sewage treatment 
facilities (Table 3) via renal (urine) and biliary (faeces) excretions then introduced into the 
environment (by STW effluent) after incomplete degradation (Jjemba, 2006; Silva et al., 
2011). 
Virtually every human and veterinary pharmaceutical, either prescription or non-
prescription, has been detected in sewage treatment works (STW) effluent (Table 1) and the 
aquatic environment at levels typically not exceeding upper ng/L. Personal care product 
(PCP) contamination often includes residues of surfactants used in detergents and soaps, 
plasticisers used in product packaging and linings, musk compounds used as fragrances, 
personal insecticides, disinfectants, among others. So-called other ECs include non-
commonly monitored agricultural chemicals (for example many herbicides, pesticides and 
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pharmaceuticals used in animal husbandry) and even residues of recreational drugs and 
their metabolites (Rosi-Marshall et al., 2015). Recent concern regarding 
groundwater/aquifer contamination by chemicals used in the hydraulic fracturing of shale 
(e.g., naphthalene used as a surfactant and tetramethyl ammonium chloride as clay 
stabiliser) may be considered novel emerging contaminants (Gordalla et al., 2013).   
Once in the aquatic environment, other than some well-researched compounds 
(e.g., BPA and ethinylestradiol), their ultimate fate (i.e., bioaccumulation, spatial 
distribution, and partition between dissolved and bound to suspended particulate material 
phases) in aquatic ecosystems is relatively unclear. Most reviews on the study of ECs tend to 
be limited to a certain chemical (e.g. BPA: Corrales et al., 2015), group of chemicals (e.g. 
endocrine disrupting compounds: Patisaul and Adewale, 2009; Fisher and Eugster, 2014) or 
on certain specific aspects of PPCPs/ECs (e.g. removal/degradation during sewage 
treatment: Luo et al., 2014). This review critically examines the most influential research, 
encompassing seven major groups of PPCPs and ECs, with a particular focus on occurrence, 
association with micro-/nanoplastic particles, and bio- and photochemical transformation. 
 
 
 
 
 
 
 
Figure 1. Sources and fate of PPCP and other ECs in the aquatic environment. 
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Table 1. Comparison of influent and effluent concentrations of 10 commonly reported 
pharmaceuticals in wastewater  
Compound STW Influent (ng/L) STW Effluent (ng/L) Source 
Atenolol 1250* 800* Jelic et al. (2011) 
795 330 Vieno et al. (2007) 
Bezafibrate  800*  400*  Jelic et al. (2011)  
4700  600  Metcalfe et al. (2003) 
Carbamazepine  
 
1050* 750* Jelic et al. (2011) 
1900  2300**  Metcalfe et al. (2003)  
Diclofenac  
 
1550* 900* Jelic et al. (2011) 
1300 ND Metcalfe et al. (2003) 
Gemfibrozil  170*  420**  Jelic et al. (2011)  
2100  1300  Metcalfe et al. (2003)  
Ibuprofen  8600 510 Guerra et al. (2014) 
Ketoprofen  2650*  800*  Jelic et al. (2011)  
5700  ND  Metcalfe et al. (2003)  
Metoprolol  130* 80* Jelic et al. (2011) 
1060  755  Vieno et al. (2007)  
 
2.0 The profile of PPCP Contamination: What’s in the Water? 
Since the use of synthetic compounds such as pharmaceuticals and personal care products 
started, these contaminants have been present in the natural and built environments (Jelić, 
2012). More than 80 compounds and several metabolites have been found in the aquatic 
environment and some in drinking water, which indicates that not all contaminants are 
removed during water treatment (Heberer, 2002). While their presence is not a new 
phenomenon, noticeable attention has been drawn to them within the last decade (Jelić, 
2012). Arguably much of this novel interest is due to recent research into the 
ecotoxicological effects on aquatic organisms of other synthetic compounds such as 
herbicides and pesticides. Product proliferation and ease of access to pharmaceuticals and 
personal care products have significantly increased the loading of such compounds in both 
the natural and built environments (National Association of Clean Water Agencies, 2012). 
The exact combination of compounds in sources of water varies from location to location 
and concentrations are consistently higher in ground and surface water than in drinking 
water (Benotti and Brownawell, 2009; National Association of Clean Water Agencies, 2012).  
Worldwide, few such compounds have been inventoried or regulated as 
contaminants (Caliman and Gavrilescu, 2009). Thus, a lack of knowledge exists regarding the 
occurrence, proliferation, impacts and fate of synthetic pharmaceuticals and personal care 
products in the environment (Caliman and Gavrilescu, 2009). Benotti and Brownawell (2009) 
found 21 different synthetic compounds in 19 different municipal water supplies in the 
United States. In this study, 51 pharmaceuticals were tested for, of which nearly half were 
detected (Benotti and Brownawell, 2009). The ten most commonly found pharmaceutical 
contaminants were: atenolol, estrone, carbamazepine, meprobamate, gemfibrozil, 
naproxen, phenytoin, sulfamethoxazole, trimethoprim, and TCEP (Benotti and Brownawell, 
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2009). Of the ten most commonly found, median concentrations were less than 10 µg/L 
(Benotti and Brownawell, 2009). While such concentrations may seem low, some 
compounds (e.g., ethinylestradiol) have been shown to be endocrine disruptors during 
critical periods of biological development in fish at concentrations as low as ≤1 ng/L (Parrott 
and Blunt, 2005; Baumann et al., 2014). Thus, particularly in terms of hormonal disruption, 
concentrations of synthetic contaminants can have biological effects at concentrations 
detected in environmental samples. 
In the United Kingdom, Jones et al. (2002) modelled aquatic concentrations of the 25 
most frequently used pharmaceuticals in the nation. Compounds ranged from sodium 
valproate, an anti-epileptic drug, to ibuprofen, an analgesic (Jones et al., 2002). Surface 
water concentrations of all contaminants were modelled with conservative estimates and 
exceeded 1 ng/L (Jones et al., 2002). Some of the most commonly used drugs in the United 
States alone are asthma medication for children, central nervous system stimulants, 
antidepressants, and cholesterol lowering medication, all of which have been detected in US 
waters (Centers for Disease Control, 2010). In 2000, the U.S. Geological Survey (USGS) began 
one of the first and perhaps still most significant reconnaissance studies of the 95 most 
common PPCPs in the United States focusing on 136 different streams and rivers running 
through intensive livestock production and urban centres (Barnes et al., 2002; Kolpin et al., 
2002). During the study, 82 of the 95 PPCPs were detected (Kolpin et al., 2002). While 
concentrations were generally low and did not often surpass U.S. drinking water guidelines 
(where guidelines exist for such contaminants), known endocrine disrupting compounds 
were discovered at physiologically active concentrations (Kolpin et al., 2002). Furthermore, 
mixtures of PPCPs present in water were common as a median of 7 contaminants and as 
many as 38 were found in individual streams or rivers bringing to light possible 
combination/synergistic effects (Kolpin et al., 2002). In recent years, research has commonly 
focused on elucidating the presence, concentrations, and at times spatial distribution of 
such contaminants in the aquatic environment (Musolff et al., 2009; Sánchez-Avila et al., 
2010; Al Aukidy et al., 2012; Li, 2014). Such research serves to indicate that contamination 
of the aquatic environment with synthetic compounds is a worldwide phenomenon. Several 
commonly reported classes of PPCPs have been observed and are discussed in greater detail 
within this chapter. Table 4 shows concentrations of 42 commonly detected PPCP/ECs in 
surface, ground and drinking water of five different countries. 
2.1 Analgesics 
Non-Steroidal Anti-inflammatory Drugs such as ibuprofen, paracetamol (acetaminophen), 
naproxen, and diclofenac are commonly used and relatively easily accessible. Prior to STW 
discharge, ibuprofen appears to be readily degraded into its two main metabolites: 
carboxyibuprofen and hydroxyibuprofen. Concentrations of parent-ibuprofen have been 
found at levels up to 24600 ng/L (4000 ng/L median) in STW effluents and at levels of 700 
ng/L in seawater (Metcalfe et al., 2003; Weigel et al., 2004). While paracetamol appears to 
be well removed during sewage treatment, Kolpin et al. (2002) identified levels of the 
parent compound of paracetamol at median levels of 110 ng/L in 24% of sampled U.S. 
streams and rivers. Other analgesics, such as codeine, were found in the same study at 
median levels of 10 ng/L in 7% of sampled streams and rivers. Analgesics such as naproxen, 
ibuprofen and paracetamol have also been detected in rivers and canals of Spain at levels of 
81 ng/L, 470 ng/L and 40 µg/L respectively (Al Aukidy et al., 2012; Li, 2014). In six Canadian 
STWs, Guerra et al. (2014) identified acetaminophen, ibuprofen, hydroxyibuprofen and 
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naproxen at respective median levels of 92000 ng/L, 8600 ng/L, 24000 ng/L and 6280 ng/L in 
all collected influent samples and 2200 ng/L, 510 ng/L, 4200 ng/L and 580 ng/L in 58%, 92%, 
67% and 100% of respective effluent samples. In the same study, acetaminophen, 
ibuprofen, 2-hydroxy-ibuprofen and naproxen were extracted from biosolids collected in 
the same sewage treatment facilities at respective median levels of 23 ng/g dry weight (dw) 
biosolid, 150 ng/g dw, 79 ng/g dw and 24 ng/g dw in 25%, 100%, 13% and 75% of collected 
samples (Guerra et al., 2014). Environmental levels of common analgesics appear relatively 
constant over recent years with median levels of naproxen and ibuprofen reported at 550 
ng/L and 200 ng/L respectively in rivers and canals of both New Jersey and Canada (Li, 
2014).  
2.2 Antibiotics 
Antibiotics are one of the oldest, most successful, and most commonly used classes of 
pharmaceuticals. Both human and veterinary antibiotics are commonly found in the aquatic 
environment (Baquero et al., 2008; Kümmerer, 2009; Martinez, 2009; Jiang, 2013; Berglund, 
2014). In addition to parent compounds, metabolites of antibiotics such as erythromycin 
and penicillin (e.g., penicilloic acid) have also been detected at levels, up to 30 ng/L in both 
ground and surface waters (Focazio et al., 2008). Sulphonamides sulfamethoxazole and 
sulfapyridine have been found in Spanish STW effluents at levels up to 18 ng/L and 28 ng/L 
as well as their acetylated metabolites at 9 ng/L and 52 ng/L respectively (Garcia-Galan et 
al., 2012). Kolpin et al. (2002) found residues of several common antibiotic contaminants in 
US streams and rivers (see Table 4) including triclosan at 2300 ng/L. Trimethoprim and 
sulfamethoxazole have also been detected at levels of 2 ng/L and 46 ng/L respectively in 
Canadian groundwater (Van Stempvoort et al., 2013), 6 ng/L and 3 ng/L respectively in 
rivers and canals of Spain (Li, 2014), and 2000 ng/L and 39 ng/L respectively in STW effluent 
in Taiwan (Li, 2014). Despite the typically low concentration of such compounds, their 
occurrence in the aquatic environment is suggested to influence the development of 
antibiotic resistance in microorganisms (Hong et al., 2013; Berglund, 2014). However, such 
findings are debated and warrant further investigation.  
2.3 Antineoplastic Compounds (ACs) 
Antineoplastic (anticancer) pharmaceutical contamination of the aquatic environment is of 
concern as their use continues to increase (Brezovsek et al., 2014). Several compounds used 
in chemotherapy have been identified in hospital wastewater, surface waters, STW facilities, 
and even estuarine waters (Thomas and Hilton, 2004; Roberts and Thomas, 2006; Fent et 
al., 2006). Among those identified include, ifosfamide, daunorubicin etoposide and 
methotrexate at concentrations of <2-10647 ng/L, <5-380 ng/L and <2-4689 ng/L 
respectively in hospital wastewater (Yin et al., 2010). In the UK, tamoxifen, a drug used in 
the treatment of breast cancer, was identified by Roberts and Thomas (2006) at levels 
ranging between 146 and 369 ng/L in STW effluents. Furthermore, levels of the same drug 
were identified in the Tyne estuary (Tyne and Wear, UK) at levels of 27-212 ng/L, indicating 
a strong environmental persistence and likely low degradation in STW facilities (Thomas and 
Hilton, 2004; Roberts and Thomas, 2006). Antineoplastic compounds appear to be 
incompletely removed by sewage treatment and not readily biodegradable (Besse et al., 
2012). Liu et al. (2010) show maximum STW influent and effluent levels of anastrozole of 
0.32 ng/L and 0.30 ng/L respectively indicating the compound is poorly removed from 
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Chinese STW. Surface water concentrations of antineoplastic compounds are typically low 
and have been reported up to 64.8 ng/L for cyclophosphamide (Moldovan, 2006), 0.14 ng/L 
for ifosfamide (Buerge et al., 2006), and 25 ng/L for tamoxifen (Coetsier et al., 2009). 
Zounkova et al. (2010) suggest some antineoplastic compounds may be found in hospital 
effluents at biologically significant concentrations to common aquatic bacteria however it 
should be noted that such biologically significant levels are currently not well-established or 
researched. 
2.4 Beta-Blockers 
Beta-blockers, or beta-adrenergic receptor antagonists, are used for the treatment of high 
blood pressure and heart attack recovery and have been identified in sewage and surface 
waters (Fent et al., 2006; Maurer et al., 2007). Such compounds commonly include sotalol, 
atenolol, metoprolol, propranolol, and bisoprolol. Atenolol and metoprolol have been 
identified at highest levels of up to 33100 ng/L and 1520 ng/L respectively in STW influent 
and 7600 ng/L and 250 ng/L respectively in STW effluents (Luo et al., 2014). Beta-blockers 
appear to be relatively degradable in STW facilities showing removal efficiencies from 56.4% 
for metoprolol to 85.1% for atenolol, for example (Maurer et al., 2007; Luo et al., 2014). 
Atenolol has been reported in multiple countries including in the ground water of France up 
to 30 ng/L (Vulliet and Cren-Olivé., 2011), Korea up to 690 ng/L (Kim et al., 2009), and the 
United Kingdom up to 680 ng/L (Kasprzyk-Hordern et al., 2009). 
2.5 Perfluorinated Compounds 
Perflourinated compounds (PFCs) are characterised by a fluorinated carbon chain of variable 
length and are commonly used as anti-stick or water repellent liners for clothing, packaging, 
automobiles, among other uses.  PFCs include compounds such as perfluorooctanoic acid 
(PFOA), used in fluoropolymers such as Teflon, and perfluorooctane sulfonate (PFOS), a 
fluorosurfactant used in stain repellents and fire-fighting foams. Other PFCs may be used in 
cosmetics and hydrophobic coatings, such as used with some clothing items (Inoue et al., 
2004). Research has shown these compounds frequently detected in the environment, even 
being found in deep arctic seas (Rudel et al., 2003; Skutlarek et al., 2006; Farré et al., 2008; 
Jahan et al., 2008; Arvaniti et al., 2015; Wilkinson et al., 2017). Perfluorinated compounds 
are not limited to the aquatic environment. PFOA and PFOS have been consistently detected 
in the vacuum cleaner dust of Japanese homes at levels up to 3700 ng/g and 2500 ng/g 
respectively (Moriwaki et al., 2003). In addition, Fluorotelomer alcohols (FTOHs), such as 8:2 
FTOH, have been detected in Japanese precipitation at concentrations up to 1.97 ng/L 
indicating the atmosphere as both a medium of transport and source of contamination 
(Mahmoud et al., 2009). Fluorotelomer alcohols are common precursors to many 
fluorosurfactants, a component of many personal care products and are so too used in the 
production of stain repellents and hydrophobic product coatings.  
Typically, PFCs are found in rivers at levels below 100 ng/L but PFOA has been 
identified in the Moehne River, Germany, at up to 3640 ng/L and perfluoropentanoic acid 
up to 1638 ng/L (Skutlarek et al., 2006). PFCs including PFOS, PFOA, and perfluorononanoic 
acid (PFNA) have been detected in port and coastal sea water at concentrations typically not 
exceeding 0.75 ng/L but have been detected by Sánchez-Avila et al. (2010) up to 8.38 ng/L 
(PFOS) in port seawater and 3.93 ng/L (PFOS) in coastal seawater. Recent evidence suggests 
levels of PFCs may be elevated in street water runoff during periods of rainfall where levels 
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of PFNA and PFOA have been reported as high as 648 and 1160 ng/L respectively in areas of 
heavy transport vehicle activity (Wilkinson et al., 2016b). Many PFCs are, at times, detected 
at higher concentrations in river water than in STW effluent water indicating their sources 
may not always be predominately wastewater-driven (Sánchez-Avila et al., 2010). Zushi and 
Masunaga (2009) suggest that concentrations of PFCs in rivers are highest in areas receiving 
runoff from heavy transportation land use (in particular near train stations). Thus, land use 
may be associated with the introduction of PFCs to rivers via runoff (rainfall-driven) events. 
 
Table 2. Amounts (in tonnes) of twelve common pharmaceuticals consumed annually 
    Country, (Year), [Population] 
Drug Class Compound England1 Germany2 France3 Germany
4,5 Spain5 
   (in Tonnes) (2000) (2001) (2008) (2010) (2010) 
    [58,789,194] [82,350,000] [64,370,000] [81,780,000] [47,020,000] 
Analgesic Diclofenac 26.12 85.8 22.64 78.58 17.4 
  Ibuprofen 162.2 344.89 58.35 250.79 218.53 
  Naproxen 35.07 n/a 37.33 n/a 56.7 
  Paracetamol 390.9 621.65 3303.08 n/a 1065.84 
Antacid Ranitidine 36.32 85.81 n/a n/a n/a 
Antibiotic Amoxicillin n/a n/a 333.22 n/a 187.76 
  Clarithromycin n/a n/a 16.89 12.36 10.86 
Anticonvulsant Carbamazepine 40.35 87.6 33.36 83.3 20.95 
Antidiabetic Metformin 205.8 516.91 n/a n/a n/a 
β-Blocker Atenolol 28.98 n/a n/a n/a n/a 
  Metoprolol n/a 92.97 n/a n/a n/a 
Lipid lowering Bezafibrate n/a n/a 20.85 39.16 6.25 
 
1Jones et al. 
(2002)  
2Huschek et al. (2004) 
3Vulliet and Cren-Olivé, 
(2011) 
 
4 ter Laak., 
(2010)  5Ortez de Garcia et al. (2013) 
*n/a, not available 
 
 
Drinking water treatment does not appear to be an absolute barrier to PFCs. Zafeiraki et al. 
(2015) quantified concentration of 11 PFCs in treated drinking water and found PFCs up to 
54 ng/L in 48.6% of tested waters near Amsterdam, Netherlands. Here, short-chain PFCs 
such as perfluoropentanoic acid and perfluorohexanoic acid were detected more frequently 
than long chain (C>8) PFCs, particularly in areas using purified surface water over 
groundwater (Zafeiraki et al., 2015).  
PFCs, and their metabolites are shown to be persistent and bioaccumulative in the 
aquatic environment and not easily degraded by microbiological or chemical treatment in 
sewage and drinking water treatment (Skutarek et al., 2006; Arvaniti et al., 2015). Schultz 
(2006) showed that mass flow of 6:2 fluorotelomer sulfonate and perfluorooctanoate 
remained unchanged through STW trickling filtration and primary clarification. Mass flow of 
perfluorooctane and perfluorodecane sulfonates increased during trickling filtration and 
activated sludge treatment due to degradation of their precursor molecules, mainly 
fluorotelomer alcohols (Schultz et al., 2006). Many PFCs appear to be metabolised to their 
sulfonate and carboxylic acid metabolites (Farré et al., 2008).  
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In recent years, many long-chain (>C7) carboxylic and sulfonic acid PFCs (e.g., 
perfluorooctanoic acid- PFOA) have been replaced by shorter, less bioaccumulative 
derivatives (Sun et al., 2016). However, resent evidence suggests that new generation short-
chain replacements such as perfluoro-2-propoxypropanoic acid (which has replaced PFOA 
for many uses) are similarly persistent through wastewater treatment and found at 
concentrations exceeding those of long-chain ‘legacy’ PFCs 630 ng/L in river water (Sun et 
al., 2016). Similarly, Wilkinson et al. (2017) quantified concentrations of short chain 
replacement perfluorobutanesulfonic acid between 1.4 to 1.7-fold higher than long-chain 
alternatives in sewage treatment effluent and receiving water bodies of southern England. 
While study indicates that long-chain PFCs may be highly persistent and bio-/accumulative 
in the aquatic environment (Sun et al., 2016), future research should focus on determining 
the environmental fate and accumulation of short-chain alternatives to traditional (>C7) 
PFCs. While no clear and significant statutory regulation of long-chain PFCs exists, 
government bodies have encouraged use of short-chain analogues through programmes 
such as the US EPA’s PFOA Stewardship Programme and the Stockholm Convention’s 
Persistent Organic Review Committee’s guidance on replacements for PFOS. Ultimately, the 
use and manufacture of long-chain PFCs has been phased out of most OECD countries with 
some production shifted to other locations (Stockholm Convention on Persistent Organic 
Pollutants, 2010). Additionally, over 150 potential short-chain and other chemical 
replacements for PFOA alone have been established under the EPA’s PFOA Stewardship 
Programme (United States Environmental Protection Agency, 2017). 
2.6 Personal Care Products (PCPs) 
Common PCPs include fragrances (musk compounds), UV filters (sunscreens), detergents, 
lotions, personal insecticides, deodorants, and cleaning products which are typically 
released through household wastewater (Peck, 2006; Roosens et al., 2007). Cleaning 
products used in domestic and industrial applications (detergents and soaps) can include 
non-ionic surfactants such as alkylphenol ethoxylates (AEOs), of which more than 90% are 
nonylphenol ethoxylates (NPEOs) (Farré et al., 2008). Compounds of interest include 4’-
nonylphenol, a well-known metabolite of NPEOs which has recently been detected up to 80 
ng/L in the Vaal River, South Africa (Chokwe et al., 2015).   
Synthetic Musk Compounds (SMCs) are commonly used in personal care products 
and are widely occurring in the environment with varying chemical structures (Roosens et 
al., 2007; Lee I. et al., 2010). These compounds were first developed at the end of the 19th 
century and have since been continually produced for fragrance in cosmetics, soaps, 
perfumes, detergents and lotions (Lee I. et al., 2010). Some of the most commonly occurring 
SMCs include Tonalide (AHTN), Galaxolide (HHCB), musk xylene (MX), and musk ketone 
(MK) and have been detected in PCPs such as lotions, perfumes, and deodorants at levels up 
to 8000 µg/g, 22000 µg/g 26 µg/g, and 0.5 µg/g respectively (Roosens et al., 2007). 
Typically, SMCs occur in Sewage treatment works (STW) influent at levels of 3690-7330 
ng/L, effluent at levels of 960-2960 ng/L, and surface water at 150-16700 ng/L (Lee I. et al., 
2010).  
Ultraviolet (UV) filters, such as benzophenone-4 (BP-4) and 2-Phenylbenzimidazole-
5-sulphonic acid (PBSA), have only relatively recently been reported in STW influent, 
effluent, surface- and at times in drinking-waters (Giokas et al., 2007; Kasprkyz-Hordern et 
al., 2008; Rodil et al., 2008; 2012). Residues of UV filters are thought to be largely seasonally 
introduced through bathing and other recreational use of water (Rodil et al., 2012). In 
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northwest Spain, Rodil et al. (2012) detected BP-4 and PBSA in all sampled STW influents at 
median concentrations of 2100 ng/L and 200 ng/L respectively. Similarly, median 
concentrations of 1200 ng/L BP-4 and 240 ng/L PBSA were found in treated STW effluent 
and up to 600 ng/L BP-4 and 20 ng/L PBSA in surface water (Rodil et al., 2012). Among UV 
filters detected in drinking water (frequency between 12-46% of samples) concentrations 
are typically below 10 ng/L except BP-4, which has been detected up to 60 ng/L in 
northwest Spain (Rodil et al., 2012).  
The implications of such PCPs in the aquatic environment is somewhat unclear when 
compared to the relatively large amount of research conducted elucidating the aquatic 
toxicity of human pharmaceuticals (Brausch and Rand, 2011). Toxicity of trace-level (ng/L to 
low µg/L) PCPs in the aquatic environment are highly debated and are reviewed in greater 
detail elsewhere (e.g., Brausch and Rand, 2011). Further research is warranted particularly 
in assessing potential endocrine disruption associated with exposure to UV-filters and 
bioaccumulation of PCPs in the aquatic environment (Brausch and Rand, 2011).  
  
2.7 Plasticisers 
Plasticisers are compounds which increase the plasticity of a material and are often involved 
in the production of plastic products/packaging, epoxy resins (coating cans for food and 
beverage), water pipe lining, thermal printing paper, implanted medical devices and in the 
production of CDs and DVDs, mobile phones, plastic food containers, eye glass lenses, 
drinking bottles, food packaging, dental sealants, among many others (Barraza, 2013; 
American Dental Association, 2016; Testai et al., 2016). Common plasticisers found in 
surface water include bisphenol-A (BPA), bisphenol-S (BPS), and bisphenol-F (BPF) which 
have recently been detected up to 98 ng/L, 135 ng/L, and 1110 ng/L respectively in the Pearl 
River, China (Yamazaki et al., 2015). Bisphenol-A has also been detected at levels of up to 50 
ng/L (average of <9 ng/L) in <5% of 291 sampled tap waters across France (Colin et al., 
2014). BPA in particular is made at one of the highest volumes of any PPCP in the world with 
more than 2 million metric tonnes produced annually (Lang et al., 2008; Maia et al., 2009). 
Despite government restrictions being placed on BPA use, the market for BPA, and hence 
the compound’s production, is poised for continued growth (see a comprehensive market 
analysis of BPA use and production: Merchant Research and Consulting, 2015). In 2011, in 
response to widespread concern over safety in the public and scientific sectors, the 
European Commission restricted the use of BPA as a monomer in the manufacture of 
polycarbonates (Grignard et al., 2012). However, since 2011, worldwide production of BPA 
has increased 5.25% annually showing total production of 4.4 million tonnes in 2011, 4.6 
million tonnes in 2012 and 5.4 million tonnes in 2015 (Merchant Research and Consulting, 
2015). Approximately 53% of BPA is produced in Asia with major centres of production in 
Taiwan, South Korea, China and Japan (Merchant Research and Consulting, 2015). 
In response to concern over environmental toxicity of BPA and the compound’s 
widespread use in thermal printer paper, the USEPA released a report outlining 19 possible 
replacements for BPA (most other plasticisers) and their associated toxicity (USEPA, 2014). 
Possible replacements include BPS, 2,4’-bis(hydroxyphenyl)sulfone (2,4-BPS), BPF, 2,2’-bis(4-
hydroxy-3-methylphenylphenyl)propane (BPC), and 4,4’-(1-Phenylethylidene)bisphenol 
(BPAP) among others (USEPA, 2014). However, it should be noted that the USEPA report 
outlines potential replacements with similar toxicity to that reported for BPA (such as for 
BPS, BPC and BPAP) or toxicity potentially higher than that reported for BPA such as in the 
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case of BPF (USEPA, 2014). Bisphenol-S is now commonly used as a plasticizer; however, BPS 
has not been extensively evaluated in terms of its environmental presence and persistence 
in surface, ground, and drinking waters (Grignard et al., 2012). Recent evidence suggests 
BPS, BPF and BPAF are present at concentrations up to 19 ng/L, 3.4 ng/L and 246 ng/L 
respectively in Chinese rivers and that BPF and BPAF may more readily associate with 
sediment at concentrations of up to 30 ng/g and 2010 ng/g respectively (Yang et al., 2014). 
In the same study BPA was quantified up to 75 ng/L in river water and 43 ng/g in sediment 
(Yang et al., 2014). Plasticisers such as BPA and BPS have also been detected in street runoff 
during times of rainfall at levels up to 2410 and 50 ng/L respectively in greater London, UK 
(Wilkinson et al, 2016b). As replacements for plasticisers limited by regulatory bodies come 
to market, further and increasing research is needed to determine the environmental 
distribution as well as fate in sediment, suspended material and biota. 
 
 
Table 3. Proportion of the parent compound excreted for 60 common pharmaceuticals 
(Upton et al., 1980; Baker et al., 1999; Jjemba, 2006) 
 
 
                Low: (≤5%) 
Moderately low: 
(6-39%) 
Relatively high: 
(40-69%) 
High: (≥70%) 
Analgesics 
Aspirin, Ibuprofen, 
Paracetamol, 
Ketoprofen, 
Neproxen 
Cromoglycate, 
Diclofenac 
Dexamethasone Morphine 
Anesthetics   Lidocaine     
Antimicrobials 
Acylovir, 
Chloramphenicol 
Ampicillin, 
Clindamycin, 
Sulfamethoxazole 
Dicloxacillin, 
Ethambutol, 
Didanosine, 
Fluconazole, 
Metronidazole, 
Minocycline, 
Norfloxacin, 
Trimethoprim, 
Valaciclovir 
Amoxacillin, 
Ciprofloxacin, 
Doxycycline, 
Cephalexin, 
Flucytosine, 
Genaconazole, 
Tetracycline 
Antineoplastics Idarubicin Temozolomide     
Cardiovascular 
Atorvastatin 
(Lipitor), Labetalol, 
Quinapril, 
Verapamil 
Enalapril (Vasotec), 
Hydrochlorothiazide, 
Procainamide, 
Qiunidine, Ramipril, 
Simvastatin (Zocor) 
Bezafibrate, 
Clonidine, Digoxin, 
Furosemide 
  
Dopamirgics   Nimodipine     
Gastrointestinal   
Domperidone, 
Rinitinide (Zantac) 
    
Reproductive     Testosterone   
Sedatives/ 
antipsychotics 
Carbamazepine, 
Valium, Fluoxentine 
(Prozac), 
Naltrexone 
Phenobarbitone, 
Primidone 
Atropine Baclofen 
Uricosuric Probenecid       
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3.0 Environmental Transport and Fate of PPCP and other Emerging Contaminants  
Traditionally, the contamination and fate of PPCPs and other emerging contaminants in 
river systems are studied through analysis of liquid samples. This is usually limited to 
monitoring parent compounds in the water (as opposed to rarer studies involving sediment, 
suspended solids and other mediums, e.g. biofilms, and other aquatic biota) of river 
ecosystems. Such an approach, while still informative in regard to contaminant attenuation 
within the water component of a river, does not represent the complete dynamics of PPCPs 
transport. Contaminant transport and fate in aquatic systems is still an evolving research 
area of PPCP environmental pollution, likely due to the relatively poorly understood and 
complex interactions between micro-organic contaminants and the environment within 
which they exist. The attenuation of contaminants in a river is very dynamic and dependent 
on specific factors relating to season, location, river hydrology, flow, biodegradation, 
association with other environmental compartments such as sediment and suspended 
particulate material, as well as river and contaminant-specific chemistry (Osenbruck et al., 
2007; Musolff et al., 2009; Luo et al., 2011). 
Point source contamination (e.g., sewage treatment facility effluent) is conceptually 
the simplest transport pathway to evaluate. After introduction into a river, contaminant 
concentrations are typically higher when effluent is discharged into tributaries with lower 
volume and slower flow rates than the main rivers, likely due to dilution effects (Silva et al., 
2011). As contaminants flow down-stream, their interaction with the aquatic environment 
becomes more complex and less well understood. Ultimate fate and attenuation of 
contaminant concentrations can occur through several pathways/mechanisms, often 
depending on the properties of each individual compound, each individual river or aquatic 
system, biotic and abiotic contaminant degradation, how and when the compound was 
introduced to the environment, and its partition to solid components of the aquatic 
environment such as suspended solids and sediment (Osenbruck et al., 2007; Musolff et al., 
2009). Much research is needed to further characterise the conditions leading to specific 
pathways of river transport and contaminant fate. 
 
Table 4. Concentration ranges of 42 commonly detected pharmaceuticals, personal care 
products and other emerging contaminants in surface water (adapted from Wilkinson et al., 
2016a) 
Contaminant Class Contaminant 
Surface water 
(ng/L) 
Analgesic Ibuprofen 1-2370a 
  Diclofenac <0.5-253a,g 
  Paracetamol 110-10000b,c,g 
  Codine 12-1000b,c 
  Naproxen <1-81
o 
Antibiotic Amoxicillin <2.5-245a 
  Erythromycin <0.5-159a 
  Triclosan 140-2300b,c 
  Trimethoprim <1-2
p 
  Sulfamethoxazole <1-46
p 
Antidepressant Amitriptyline 66-207a 
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  Fluoxetine 5.8-120a,b 
  Venlafaxine 1.1-35a 
Antineoplastic Ifosfamide 0.05-.14d 
  Cyclophosphamide 0.05-0.17
d 
  Tamoxifen <0.05-25
n 
Alkylphenols 4-nonylphenol 165.8-1187.6e 
  4-t-octylphenol 2.4-14.5e 
Beta Blocker Metoprolol <0.5-10a 
  Atenolol <1-487a 
Hormones/Steroids 17α-ethynylestradiol <0.98-10.2g 
  17β-estradiol 0.1-200a,b 
  19-norethisterone 48-872a,b 
  Coprostanol <1-2717
h 
Lipid regulator Bezafibrate <10-60a 
  Gemfibrozil 48-790b,c 
Musk Compounds Linalool <0.5-0.6q 
  Isobornyl acetate <0.18-0.65q 
  Aroflorone <0.17-0.48q 
Perfluoroalkyls 8:2 Fluorotelomer Alcohol <0.9-1.97m 
  Perfluorobutane sulfonic acid* 2.4-125f,g 
  Perfluoro-2-propoxypropanoic acid* <1-630l 
  Perfluorononanoic acid 0.03-209f,g 
  Perfluorooctanoic acid 0.16-189
f,g 
  Perfluorooctane sulfonic acid 0.4-2709
f,g 
Plasticiser Bisphenol-A 140-12000a,b,c,g 
  Bisphenol-S** <1.02-306
g 
  Bisphenol-AF** <1-246i 
  Bisphenol-F** <1-1110
j 
  Diethyphthalate 200-420
b,c 
Ultraviolet Filters Benzophenone-4 <1-600
k 
  2-Phenylbenzimidazole-5- sulfuric acid <1-20
k 
*Compound used or proposed as a replacement for long-chain (>C7) perfluorinated compounds 
** Compound used or proposed as a replacement for bisphenol-A 
 
a
Petrie et al. (2015); 
b
Kolpin et al. (2002); 
c
Boyd et al. (2004); 
d
Buerge et al. (2006);   
e
Wang et al. (2012); 
f
Llorca et al. (2012); 
g
Wilkinson et al. (2017); 
h
Peng et al. (2008); 
i
Yang et al. 
(2014); 
j
Yamazaki et al. (2015); 
k
Rodil et al. (2012); 
l
Sun et al. (2016); 
m
Mahmoud et al. (2009); 
n
Coetsier et al. (2009); 
o
Li (2014); 
p
Van Stempvoort et al. (2013); 
q
Relic et al. (2017) 
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3.1 Atmospheric Transportation and Precipitation 
The atmosphere has been indicated as both a transport mechanism and source of several 
volatile PPCPs and other ECs (Hayes et al., 2002; 2003; Oono et al., 2008; Mahmoud et al., 
2009). Fluorotelomer alcohols (FTOHs) are commonly reported emerging contaminants in 
the atmosphere and precipitation. FTOHs are widely produced with an estimated global 
production of 1.1-1.4 million kg/year and are commonly used as fluorotelomer-based acrylic 
polymers in water repellents for cloths, paper, packaging and carpet (Oono et al., 2008). The 
two most common FTOH compounds found in the atmosphere, 8:2 FTOH and 6:2 FTOH, 
were detected across 33 locations in Japan at concentrations of 32-247 pg/m3 and <LOD-
768 pg/m3 respectively (Oono et al., 2008). FTOH compounds have also been detected in 
Japanese precipitation and surface waters at concentrations ranging from 0.21-1.97 ng/L 
and 0.16-3.38 ng/L respectively (Mahmoud et al., 2009).  
 Volatile emerging contaminants may enter the atmosphere via volatilisation from 
surface water or STWs as well as atmospheric emission during manufacture or incineration. 
Reviewing recent trends in the analysis and occurrence of PPCP/ECs in air, Salgueiro-
González et al. (2015) suggest many common endocrine-disrupting compounds may 
associate with airborne particulate material (PM) less than 10 µm in diameter. Furthermore, 
such contaminant-PM associates may be a potential source of such compounds to humans 
and other air-breathing organisms (Salgueiro-González et al. 2015). Levels of PM-bound 
contaminants are often significantly higher in indoor air than outdoor air, potentially due to 
poor ventilation and the widespread use of many such compounds in plastics and cleaning 
spray products (Rudel and Perovich, 2009; Salgueiro-González et al., 2015). Levels of 
commonly detected endocrine-disrupting phthalates, dibutyl phthalate (DBP), di(2-
ethylhexyl)phthalate (DEHP) and nonylphenol (NP) have been detected in outdoor air at 
levels of 55 ng/m3 (Salgueiro-González et al. 2013), 45 ng/m3 (Salapasidou et al., 2011) and 
30.5 ng/m3 (Saito et al., 2004) respectively. In indoor air, DBP, DEHP and NP have been 
detected at significantly higher levels of as much as 2300 ng/m3 (Bergh et al., 2011), 1000 
ng/m3 (Rudel et al., 2003) and 680 ng/m3 (Saito et al., 2004) respectively. Further research is 
warranted to assess whether such airborne endocrine-disrupting compounds may influence 
inputs into the aquatic environment and indeed health implications on organisms exposed 
to such compounds, whether in air or water (Salgueiro-González et al. 2015). 
Other contaminants, such as the herbicide atrazine, have been detected in 
precipitation geographically isolated from source areas, potentially entering the atmosphere 
via their application to land as sprays (Hayes et al., 2002; 2003). Rudel et al. (2003) detected 
endocrine-disrupting compounds including plasticisers, emulsifiers, nonylphenols, and an 
adhesive (4-tert-butylphenol) in the air of 52 of 89 homes tested at concentrations ranging 
from 50-1500 ng/m3. Furthermore, as discussed in section 2.1, agricultural spray drift of 
certain ECs used, for example in fruit tree production, can also transport such compounds 
atmospherically (Daughton, 2006). It is unclear how far such volatile compounds can travel 
in the atmosphere before entering the aquatic environment or being deposited on land 
through precipitation and more research is needed on this subject. 
 
3.2 River Flow and Adsorption to Sediment and Suspended Solids 
PPCPs and other ECs appear to attenuate in rivers at different rates largely depending on 
their sorption affinity to suspended solid/ sediment material (a higher affinity, indicating 
increased attenuation) and recalcitrance to biodegradation (a lower recalcitrance indicating 
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increased attenuation) (Osenbruck et al., 2007). For example, carbamazepine, an 
antiepileptic, appears to attenuate in river water much slower than galaxolide, a musk 
compound commonly used in fragrances for soaps and detergents (Osenbruck et al., 2007). 
However, it is important to note that this attenuation does not necessarily indicate the 
compound has been removed. Adsorption to suspended solids in river water, sediments and 
banks can account for PPCP/EC contaminant attenuation, with some compounds 
preferentially binding to suspended solids rather than remaining dissolved (Luo et al., 2011; 
Silva et al., 2011). The antibiotic tetracycline, for example, appears to bind more 
preferentially to suspended solids and sediment than other antibiotic contaminants such as 
sulfonamides, quinolones and macrolides. Adsorption to suspended solid material is 
suggested to aid in the transportation of such compounds in the aquatic environment 
(Gregg et al., 2015). The physiochemical characteristics of contaminants as well as the 
properties of the adsorbing material itself are important in determining environmental fate 
(e.g., Luo et al., 2011; Wilkinson et al., 2017).   
Luo et al. (2011) describe that cation exchange capacity and organic matter content 
of suspended solid material and sediment exert a great influence on contaminant 
adsorption (higher exchange capacity and organic matter indicating increased adsorption) 
and, in turn, attenuation. Similarly, Wilkinson et al. (2017) found that amphipathic 
compounds with long (C>7) linear chains and polar moieties were more likely to adsorb to 
solid material found in the aquatic environment than those with short-chains or particularly 
non-polar molecules without ionisable functional groups (Wilkinson et al., 2017). High river 
flow rates are also suggested to decrease contaminant adsorption to solid material by 
limiting or preventing adequate contact time (Luo et al., 2011). Luo et al., (2011) found 
sulfonamides, quinolones and macrolide antibiotics were more significantly affected by 
increased river flow preventing their adsorption onto sediment and suspended solids than 
tetracycline (Luo et al., 2011). Compounds showing basic (pka>7) and hydrophobic 
characteristics appear to preferentially bind to suspended solids and sediment (Silva et al., 
2011).  At times, many preferentially-bound contaminants may not even be detected in the 
dissolved fraction of the aquatic environment, existing almost exclusively in suspended 
solids and sediments (Silva et al., 2011). Some common aquatic contaminants such as 
nonylphenol and nonylphenol monoethoxylate are found in suspended solid material and in 
sediment up to 21.5 and 4.7 times higher respectively than dissolved in river water 
(Patrolecco et al., 2006; Silva et al., 2011). Similarly, Gregg et al. (2015) demonstrate that 
polycyclic aromatic hydrocarbons bind to suspended particles in the Columbia River Estuary 
(northwest USA) at levels up to 10 times higher relative to those found dissolved in 
respective water. However, other common contaminants such as diazepam, erythromycin, 
gemfibrozil and metoprolol are found predominately, if not exclusively, dissolved in the 
aquatic environment rather than bound to solid fractions (Patrolecco et al., 2006; Silva et 
al., 2011).  
It should be noted however that while levels of chemicals bound to suspended 
material are commonly reported in mass/mass units (e.g., ng/g dry weight), a more accurate 
comparison of their distribution may be reported as mass/volume of water the suspended 
material was separated from (e.g., ng/L water the suspended material is separated from). 
Where levels of suspended particulate material in water are low, vast amounts of water 
may be needed to extract as little as 1 g of suspended material, making comparison to 
dissolved contaminant concentrations in a single litre of water potentially misleading. 
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Research indicates that PPCP and other EC concentrations are generally lower in 
river sediment than suspended solids or in water (Silva et al., 2011). However, such findings 
remain relatively unclear, particularly regarding degradation product adsorption to 
suspended solids and sediments. Table 5 shows the measured concentration ranges of 14 
pharmaceuticals in the surface water, suspended solids, and sediment of various rivers. 
Such data demonstrate that detection in the dissolved fraction of the aquatic environment 
alone is not an adequate measure of PPCP/EC occurrence 
 
3.3 Biodegradation of Organic Contaminants  
All PPCPs and other ECs will eventually degrade into other, less well-characterised 
compounds. Biological degradation transitions are generated by human and animal 
metabolism and by microorganisms present in sewage treatment works (STW), occurring 
naturally, in suspended solids, or sediments (Ferrando-Climent et al., 2012).  Such 
transformations may occur via hydrolysis, oxidation, reduction and complete mineralization 
into inorganic carbon, oxygen, nitrogen or hydrogen mediated by microbes (Christensen and 
Li, 2014). High rates of biodegradation are typically observed in the sediment-water 
interface, wetlands and swamps with efficiency dependent on factors such as temperature, 
nutrient availability, pH, river flow and salinity (Christensen and Li, 2014). Traditionally, 
research has focused on the presence of parent compounds in the aquatic environment 
rather than biodegradation transitions and much research is still needed to characterise 
PPCP/EC breakdown pathways and resulting molecules. Pharmaceuticals in particular are 
expected to breakdown along the metabolism of those taking them, resulting in an initial 
presence of degradation products in sewage treatment influent as contaminants themselves 
or glucuronide-transitions.  
Microorganisms such as bacteria, fungi, microalgae and protozoa tend to degrade 
contaminants to a much greater degree (some to mineralization) than humans and animals, 
which often only transform organic compounds (e.g., via conjugation with glucuronides and 
sulfates) to a limited degree (Kumar et al., 2012; Christensen and Li, 2014). It is suggested 
that microbes may facilitate de-conjugation of excreted transformations. Kumar et al. 
(2012) show that glucuronide-conjugates of estrone and estradiol are completely 
transformed back to free parent estrogens during activated sludge treatment while sulfate-
conjugates are more resistant as only 10-55% were converted to parent estrogens. Similarly, 
in surface water, de-glucuronidation of estrone and estradiol yielded 60-100% parent 
estrogens at a half-life of 2 days (Kumar et al. 2012).  
Enzymes are indicated to play an important role in the biodegradation of organic 
contaminants. Although precise degradation pathways are relatively unclear, overall 
enzyme-dependent degradation of PPCPs/ECs is suggested (Christensen and Li, 2014) to 
occur via a certain sequence of events: 1) transport of contaminant to microbe in a 
bioavailable manner (some hydrophobic contaminants may become unavailable for uptake 
by association with suspended solids), 2) contaminant uptake and diffusion through cell 
walls (to intracellular enzymes), 3) binding to enzyme reaction site and formation of 
contaminant-enzyme complex, 4) enzyme-contaminant reaction often mediated by 
cofactors and coenzymes and 5) release of the transformed product. It should be noted 
however that reaction sites are highly specific and attachment to and passage through 
biological membranes are largely dependent on the polarity and chemical composition of 
the specific contaminant. For example, hydrophobic PPCPs/ECs may more easily attach to 
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the membrane and become more quickly degraded than hydrophilic compounds when the 
rate determining step is adsorption-dependent (Christensen and Li, 2014). 
 Contaminants are known to degrade during sewage treatment, particularly during 
activated sludge processing. Here microorganisms in biofilms degrade organic contaminants 
in a similar way as both fixed biofilms (more influential in small streams) and mobile 
aggregate biofilms (more influential in larger rivers) can degrade such organic compounds in 
the natural environment (Winkler et al., 2001). It should be noted however that there is a 
considerable lack of research into the role natural biofilms play in the environmental 
metabolism of organic contaminants. Within activated sludge treatment, Remberger et al. 
(2008) found the two main breakdown transitions of ibuprofen, hydroxyl- and carboxyl-
ibuprofen, at higher concentrations than the parent compound in sewage effluent. While 
ibuprofen is relatively well studied and good example of biodegradation, further research is 
needed to elucidate breakdown transitions and pathways of other common PPCPs and ECs. 
The toxicity of breakdown products, biodegraded or not, should also be considered as 
transformation products are indicated to be equally or more toxic (see section 6.4.3) as 
parent compounds (Ruggeri et al., 2013; Bergheim et al., 2014). 
 
Table 5. Concentrations of 14 PPCP and other ECs in surface water, suspended solids, and 
sediment (Patrolecco et al., 2006; Silva et al., 2011) 
Compound River Water    (ng/L) Suspended Solids 
(ng/g) 
River Sediment (ng/g) 
Acetaminophen n.d.-872 n.d.-657 n.d.-222 
Atenolol n.d-1237 3.06-34 n.d.-3.78 
Diazepam n.d-2.68 n.d. NA 
Diclofenac n.d.-148 n.d.-468 <LOQ-2.65 
Erythromycin n.d.-42.4 NA n.d.-33.5 
Gemfibrozil n.d.-160 n.d.-47.1 n.d.-5.2 
Ibuprofen n.d.-541 n.d.-571 n.d.-20.9 
Metoprolol n.d.-33.88 n.d.-7.59 n.d.-4.1 
Naproxen n.d.-109 n.d.-38.5 n.d.-1.87 
Ranitidine n.d.-84.5 19.4-133 n.d.-25.1 
Bisphenol-A 60-90 <LOQ-610 <LOQ 
Nonylphenol 150-340 2680-7320 380-970 
Nonylphenol 
monoethoxylate 
190-480 1320-2260 250-1780 
Nonylphenol 
diethoxylate 
70-400 <LOQ-2430 50-320 
LOQ - Limit of Quantification n.d. - Not Detected NA - Not Analysed 
 
 
3.4 Photochemical Transformation in the Aquatic Environment 
 
Photochemical transformation (or degradation) of organic contaminants in the aquatic 
environment occurs by both direct absorption of solar radiation and indirectly via reaction 
with photo-sensitized species. Via both direct and indirect mechanisms, energy from solar 
radiation results in the transformation of organic contaminants into other molecules by 
breaking covalent bonds typically resulting in more biodegradable and hydrolysable 
compounds (Richard and Canonica, 2005). Factors affecting the efficiency of photochemical 
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transformation include the mechanism of degradation (direct or indirect), chemical nature 
of the compound being degraded, temperature, pH, depth below the water surface, cloud 
coverage, altitude, latitude, and time of day (Remucal, 2014; Christensen and Li, 2014). 
While the degradation of specific contaminants via both direct and indirect photochemical 
transformation may be calculated or experimentally determined, generalising degradation 
potential across whole classes of compounds is difficult and often not reliable (Remucal, 
2014). It should be noted however that photochemical transformation has been indicated as 
a means by which to degrade PPCP/ECs in STW effluent. Despite debate regarding the 
toxicity of some transformation products (Boreen et al., 2003; Latch et al., 2003b; Ruggeri et 
al., 2013; Bergheim et al., 2014), photocatalysis, photo-Fenton and UV with H2O2 have 
shown promising removal efficiencies and are reviewed in greater detail elsewhere as 
wastewater treatment strategies (e.g., Pereira et al., 2007; Ikehata et al., 2008; Wang and 
Xu, 2012). 
 
3.4.1  Direct Photochemical Transformation 
 
Direct photochemical transformation involves the non-reversible bond cleavage or re-
arrangement of organic molecules by the energy (photons) contained in sunlight reaching 
the Earth’s surface, atmosphere, and shallow regions of the aquatic environment (Remucal, 
2014). It should be noted that direct photochemical transformation of PPCPs/ECs in the 
aquatic environment is limited by the depth of water in which the compounds are found 
(Jasper and Sedlak, 2013). The majority of ultraviolent light, for example, is absorbed within 
the top 2 m of water (Dabrowska et al. 2004). 
Sunlight reaching the earth’s surface and shallow depths of the aquatic environment 
ranges in wavelength from about 290 to 600 nm (Dabrowska et al., 2004). Corresponding 
photo energy is of a similar order to many common covalent bonds found in organic 
contaminants (400 to 200 kJ/ mol) such as C-C, C-H, C-O, C-Cl and C-Br (Christensen and Li, 
2014). The π-bond configuration of organic contaminants in the aquatic environment largely 
determines the absorptive capability (of sunlight) of the molecule via interaction with un-
bound electrons of heteroatoms such as nitrogen and oxygen (Christensen and Li, 2014). 
Most alcohols, acids, ethers and esters as well as most aliphatic hydrocarbons do not absorb 
light reaching the earth’s surface (Christensen and Li, 2014). However, increased 
susceptibility to photochemical transformation is observed in molecules containing 
functional groups (e.g., -CH=CH2, -NO2, -NH2, -N=N-, and -OH) that are capable of donating 
additional π-electrons, thereby strengthening conjugated bonds (Christensen and Li, 2014). 
The absorption efficiency of light is assessed by the reaction quantum yield (Ф), calculated 
by the ratio of transformed moles to the total moles absorbing the light (Bezarez-Cruz et al., 
2004). Reaction quantum yields >1 indicate chain reactions and most aquatic organic 
compounds show reaction quantum yields <0.01 (Christensen and Li, 2014). Not all 
absorbed energy results in the transformation of absorbing molecules. Christensen and Li 
(2014) describe three alternative routes for absorbed photo energy: 1) energy may be 
released when excited molecules deactivate to ground state by either phosphorescence or 
fluorescence, 2) absorbed energy may be consumed by the respective molecule providing 
additional kinetic energy, and 3) energy may result in heat produced by collision with other 
molecules. Many organic contaminants are photodegraded by some combination of direct 
and indirect mechanisms.  
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3.4.2 Indirect Photochemical Transformation  
 
This pathway is mediated by chromophoric components in the aquatic environment which 
are photosensitized (or photo-induced/ excited) by solar radiation and then pass the excited 
energy on to organic compounds breaking chemical bonds and degrading the molecule 
(Richard and Canonica, 2005; Remucal, 2014). The occurrence of such reactions is 
dependent upon the amount of chromophores in the aquatic system and their ability to 
react (once sensitized) with respective organic contaminants. Such a pathway may be the 
dominant degradation process for aquatic contaminants that poorly absorb solar radiation 
directly (Richard and Canonica, 2005). Sensitizers absorb light (photons) becoming reactive 
photooxidant radicals such as RO, ROO, HO, HOO, 1O2, O2
-, and CO3
- via reaction of 
bicarbonate and OH (Jasper and Sedlak, 2013; Christensen and Li, 2014; Remusal, 2014). 
Dissolved organic matter (DOM) can also act as a sensitizer (triplet DOM) in addition to 
inorganic species such as NO2
- and NO3
- (Dabrowska et al., 2004; Christensen and Li, 2014). 
Similar to energy lost in direct transformation, not all photosensitized species pass their 
excited energy on to break down organic contaminants. Photosensitized species may use 
their energy to deactivate others in a process called quenching making the resulting 
molecules less reactive (Christensen and Li, 2014). DOM may also decrease the efficiency of 
phototransformation by acting as an antioxidant and/or a sink for organic contaminants 
(Remucal, 2014). 
 
3.4.3 Photochemical Transformation of PPCPs/ECs in the Aquatic Environment 
 
The rate of PPCP/EC photochemical degradation is the sum of both direct and indirect 
transformations (Dabrowska et al., 2004). For example, in addition to thermal dissociation, 
phenol is degraded into oxalic acid and methanoic acid via both direct absorption of solar 
radiation and indirectly through oxidation by hydroxyl radicals in water (Wu et al., 2001; 
Dabrowska et al., 2004). However other PPCPs may undergo photochemical degradation 
more selectively, if at all. For example, cimetidine is photodegraded in water indirectly via 
reaction with singlet oxygen and is not susceptible to direct photochemical transformation 
(Latch et al., 2003a). Diclofenac has been shown to degrade into 1-(8-chlorocarbazolyl)acetic 
acid via photocyclization with further photochemical transformation via dechlorination 
resulting in carbazole products (Boreen et al., 2003). However, compounds with a high 
affinity for solids (such as tetracycline) may avoid photochemical degradation via sorption to 
suspended particulate materials (Boreen et al., 2003). As mechanisms of degradation and 
environmental distribution may differ between compounds and within groups of PPCPs/ECs, 
photoreactivity must be studied on a case-by-case basis (Boreen et al., 2003). It should be 
noted that study of photochemical degradation rates is often conducted in complete solvent 
or partial water-solvent systems and care must be taken in applying such findings to real-
world conditions (Christensen and Li, 2014). For example, Packer et al. (2003) determined 
diclofenac readily degraded by direct photochemical transformation and the addition of 
isopropyl alcohol to the aqueous system resulted in a more rapid transformation, 
potentially due to formation of other radical species.  
While much research has focused on determining photochemical degradation rates 
and quantum yields rather than elucidating mechanisms and transformation products, 
detailed review of photochemical transformations is available (e.g., Boreen et al., 2003; 
Wols and Hofman-Caris, 2012). Detailed research is needed in particular to determine 
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toxicity of phototransformation products which can be equally, if not more biologically 
active than parent compounds (Boreen et al., 2003; Latch et al., 2003b; Ruggeri et al., 2013; 
Bergheim et al., 2014). Ibuprofen is shown to degrade via both direct and indirect 
photochemical transformation into 4-isobutylacetophenone (IBAP) which is known to 
adversely affect the central nervous system, red blood cells and connective tissue (Ruggeri 
et al., 2013). Here, transformation occurs via reaction with hydroxyl radicals (2.3±0.1% 
yield), direct photolysis (25±7% yield) and reaction with excited DOM (31±4% yield) 
producing IBAP concentrations up to approximately 15% of ibuprofen levels in respective 
water (Ruggeri et al., 2013). Similarly, Latch et al. (2003b) determine that triclosan degrades 
via exposure to UV light into the potentially toxic 2,8-dichlorodibenzo-p-dioxin in aqueous 
medium with condition-specific yields of 1-12%. Noting the difficulty of product 
identification, Boreen et al. (2003) suggest coupling biological assays with photochemical 
studies. Here, potential biological effects of photochemical transformation products may be 
assessed without identifying the products themselves by comparing changes in biological 
endpoints before and after transformation of the parent compound. Using such 
methodology, Bergheim et al. (2014) tested the direct photodegradability and toxicity of 14 
pharmaceuticals found in the aquatic environment (acyclovir, allopurinol, cetirizine, 
cimetidine, fluconazole, hydrochlorothiazide, lisinopril, phenytoin, primidone, ranitidine, 
sotalol, sulpiride, tramadol and valsartane). Of the selected pharmaceuticals, acyclovir, 
allopurinol and fluconazole resisted direct photochemical transformation via exposure to 
UV light (Bergheim et al., 2014). Furthermore, irradiated solutions of 8 mg/L cetirizine, 
cimetidine, tramadol and valsartane demonstrated higher toxicity in growth inhibition 
assays to bacteria P. putida than non-irradiated solutions. Similarly, irradiated solutions of 
hydrochlorothiazide, ranitidine, sulpiride tramadol and valsartane showed greater inhibition 
of V. fischeri bioluminescence than non-irradiated solutions (Bergheim et al., 2014). 
Identification of photochemical transformation products as well as assessment of 
their potential ecological impacts and environmental occurrence remain relatively under-
studied topics (Bergheim et al., 2014). Future research should proceed with focus on the 
environmental occurrence and toxicology of photochemical transformation products 
identified by primary laboratory work.  
 
3.5 PPCPs and other ECs in Sewage Biosolids used as Agricultural Additives 
Biosolids are an end product of sewage treatment and are used as agricultural conditioners 
and fertilisers. Agricultural use of such municipal biosolids has increased in the EU since a 
commission prohibition on their disposal at sea in 1998 (Barron et al., 2010). The U.S. 
Environmental Protection Agency (USEPA) estimates about 50% of biosolids produced in the 
USA are used for agricultural purposes on less than 1% of the nation’s farmland (USEPA, 
2012). Throughout treatment, sewage sludge retains many contaminants, including a 
complex mixture of PPCPs and other emerging contaminants. The use of such biosolids on 
agricultural lands inevitably introduces organic contaminants including PPCPs which may 
ultimately result in soil contamination, groundwater recharge to aquifers, runoff, and 
possible uptake by agricultural plants (Daughton, 2006; Barron et al., 2010). Introduction of 
emerging organic contaminants to soil in this manner has raised concern over recent years. 
Current regulation on the quality of biosolids used for agricultural purposes does not take 
contamination by PPCP and other ECs into account (USEPA, 2012). 
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 The fate and persistence of biosolid-borne PPCP contaminants in soils appear to be 
compound-, site/soil-, and climate-specific. While hydrophobicity and soil organic carbon 
content do affect contaminant adsorption, they are alone not sufficient variables in 
estimating PPCPs behaviour in soils (Barron et al., 2010). Variables more significantly 
affecting contaminant adsorption in soils (via the application of biosolids to topsoils) may 
include the degree of soil water-saturation, rate of percolation, physicochemical properties 
of both the solid matrix and compounds, temperature of the soil, and pH of the soil/liquid 
solution (Barron et al., 2010).  
Reviewing the use of biosolids in agricultural soil, Clarke and Smith (2011) conclude 
that despite over 143,000 chemicals being registered for industrial use in the European 
Union (all of which could potentially be found in biosolids), the risk of contaminant uptake 
into agricultural plants causing implications on human health is not significant. PPCPs and 
other ECs are detected in sewage biosolids at concentrations typically not exceeding 10 
mg/kg dry weight (dw), although exceptions do exist (Clarke and Smith, 2011). For example, 
pharmaceuticals ciprofloxacin and ofloxacin have been detected up to 40.8 and 58.1 mg/kg 
dw sludge respectively in the USA (US EPA, 2009) while plasticisers bisphenol-A (BPA) and 
bis(2-ethylhexyl) phthalate (DEHP) have been detected up to 325 mg/kg dw (Meesters and 
Schroder, 2002) and 3514 mg/kg dw (Abad et al., 2005) in Germany and Spain respectively.  
Further research is warranted particularly regarding such contaminants leaching into 
the aquatic environment, including into aquifers. Additionally, with increased demand to 
recover phosphorus from wastewater treatment facilities, including from sludge (Melia et 
al., 2017), study should be undertaken to evaluate the effect of phosphorous recovery on 
concentrations of PPCPs/ECs in biosolids and in phosphorus recovery products. 
 
3.6 Temporal and Seasonal Effects on PPCP and ECs in water 
 
Many of the factors affecting contaminant attenuation can fluctuate with seasonal and 
meteorological changes (Vieno et al., 2005; Musolff et al., 2009). Most notable fluctuations 
seemed to be linked to temperature changes in receiving waters, volumes of receiving 
waters, and changes in seasonal PPCP/EC use (e.g., sunscreens, personal insecticides and 
caffeine). During warmer months, increased water temperature has been associated with 
increased attenuation of contaminants in surface waters, potentially due to increased 
microbial and biofilm activity (Musolff et al., 2009). Changes in river volume can also affect 
the concentration of contaminants, mainly by dilution. For example, Vajda et al. (2008) 
describe how the increased stream volume of Boulder Creek (Colorado, USA) during warmer 
months, due to snowmelt from the Rocky Mountains, reduces the dominance of STW 
effluent in river volume (and hence PPCP and EC discharge) by as much as >75%.  
Last, temporal and seasonal changes in compound use occur and can directly affect 
concentrations of PPCPs/ECs in the aquatic environment. In the city of Leipzig (Germany), 
periods of rainfall and colder months saw increased loading of both caffeine and 4-
nonylphenol indicating weather and season as factors in contaminant loading (Musolff et 
al., 2009). It is unclear how seasonal changes in population can affect environmental loading 
of PPCP and other emerging contaminants. Such population fluctuations could be a factor in 
cities with seasonal tourism or high student populations (e.g., university towns). However, 
research is lacking in terms of the exact affect population fluctuation has on contaminant 
loading. 
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3.7 Micro- and nanoplastic particles in the aquatic environment 
Evidence exists suggesting that certain PPCP and other EC contaminants may bind to plastics 
particles in the aquatic environment (Mato et al., 2001; Rios et al., 2007; Teuten et al., 2009; 
Hirai et al., 2011; Wegner et al., 2012; Rochman, 2016). Microplastics are defined by a 
diameter of 1 m-5 mm while nanoplastics a diameter of <1 m (Browne et al., 2008). 
However, it should be noted that the very definition of nanoplastics is debated as the 
European Commission defines nanoplastics with a particle diameter between 1 nm-100 nm 
(Europe Commission, 2015).  
Plastic particles, which are ubiquitous in the aquatic environment, do not 
biodegrade, but do however do degrade (National Oceanic and Atmospheric Administration, 
2016). In addition to being used in cosmetic products (i.e., facial scrubs and toothpaste), 
microplastic particles are formed via the degradation of larger (manufactured state) plastic 
objects over hundreds of years and may never be completely eliminated from the 
environment (National Oceanic and Atmospheric Administration, 2016). Both primary 
production and fragmentation (e.g., via ultraviolet light exposure) of larger plastic particles 
into micro-and nanoparticles are thought to be major contributors to the substantial 
amounts present in the aquatic environment (Eriksen et al., 2014). Fragmentation of 
microplastics into nanoplastics increases surface area to volume ratio which in turn may 
affect the area of plastic available for organic contaminants to bind (European Union 
Commission, 2011). Woodall et al. (2014) report abundance of microplastics in ocean 
sediment up to 4 orders of magnitude higher than that detected in sea-surface water 
indicating that sediment may be a significant sink for these contaminants. In the same 
study, plastic microparticles were identified in all sediment samples at abundances ranging 
from 1.4-40 pieces/50 mL sediment and consisted predominately of rayon and polyester 
(Woodall et al., 2014). 
Some organic contaminants have been shown to bind to plastic particles in the 
aquatic environment at similar concentrations to suspended solids and sediments (Mato et 
al., 2001; European Union Commission, 2011; Rochman, 2016). Among the first to 
demonstrate this, Mato et al. (2001) recovered PCBs, DDE, and nonylphenols bound to 
plastic particles at concentrations of 4-117 ng/g plastic, 0.16-3.10 ng/g, and 0.13-16 ng/g 
respectively. More recently, Hirai et al. (2011) found hydrophobic contaminants more likely 
to accumulate on plastics. In the same study, common ECs were detected on plastic 
particles at up to 730 ng BPA/g plastic and nonylphenol up to 3936 ng/g (Hirai et al., 2011). 
However, it is important to note that plasticisers such as BPA and nonylphenol have been 
shown to leach from plastic material such as polyethylene, silicone (nonylphenol only), 
polycarbonate and polystyrene (Fasano et al., 2012).  Hence, levels of these chemicals found 
on plastic particles in the environment may only represent desorption from the plastic itself 
during extraction in the laboratory rather than adsorption of the chemicals to the plastic 
from the environment, or a combination of both. Study investigating the accumulation of 
ECs and PPCPs onto micro- and nanoplastics in the environment is limited but is rapidly 
increasing in recent years. Research is likely most significantly limited by the difficulties in 
retrieving such particles from environmental matrices.  
Aquatic organisms may ingest plastic particles, perhaps mistaking them for eggs, 
bringing to light a possible route of exposure when PPCPs/ECs are bound to the particles 
(Mato et al., 2001; Wegner et al., 2012). Boerger et al. (2010) found ingested plastic 
particles in 35% of plankton-eating fish caught in the North Pacific Gyre. Similar findings 
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were reported in Brazilian estuaries where 18-33% of collected catfish were found with 
plastic particles in their stomachs (Possatto et al., 2011). Ingestion of contaminated particles 
may influence biological disruption in exposed organisms (European Union Commission, 
2011) and may result in the bioaccumulation of adsorbed chemicals in animals that 
consume the particles (Rochman, 2016). The degree to which levels of contaminants 
attached to plastic particles may affect the biology of the organisms, consuming them is not 
well-known and may be specific to the species and period of development an individual is 
exposed (Rochman, 2016).  
 The presence of plastic micro- and nanoparticles in the environment is likely to 
remain a key issue in the field longer than many others due to the amounts of the material 
in the aquatic environment and its inability to fully degrade (National Oceanic and 
Atmospheric Administration, 2016). In recent years, regulatory and government bodies have 
begun banning the use of microplastic particles in cosmetic products (Table 6).  
 
Table 6. Summary of significant regulation set on the sale, manufacture and import of 
products containing plastic microparticles across the world as of early 2017 
Country 
Implementation 
Date Regulation Comments 
Canada 1 July, 2018  Changes to the 
Canadian 
Environmental 
Protection Act 
Ban on the sale of shower gels, facial scrubs and 
toothpaste containing plastic microbeads from 1 July 
2018. Manufacture banned six months before the 
sales ban. Additional ban on natural products and 
non-prescription drugs containing microplastics from 
1 July, 2019.  
France Proposed: 1 
January, 2018 
Proposed at the 
time of writing 
Prohibit the sale of cosmetic products containing 
microplastic particles and cotton buds with plastic 
stems in France. 
New 
Zealand 
1 July, 2018  Changes to the 
Waste Minimisation 
Act of 2008 
Ban on the manufacture and sale of personal care 
products containing plastic microbeads. Penalty of 
$73,000 (USD) for any entity found in breach of the 
ban (Waste Minimisation Act of 2008). 
South 
Korea 
Proposed: July 
2017 
(manufacture and 
import), July 2018 
(cosmetic product 
sale) 
Proposed at the 
time of writing 
Ban on the manufacture and import of cosmetic 
products containing plastic particles from July 2017 
and ban their sale from July 2018. 
Taiwan Proposed: 2017 Proposed at the 
time of writing by 
Taiwan's 
Environmental 
Protection Agency 
Prohibits the sale, import and manufacture of 
personal care products and toothpastes containing 
plastic particles. 
United 
Kingdom 
Proposed: 
October 2017 
Proposed at the 
time of writing 
Prohibits the manufacture and sale of cosmetic 
products and personal care products which contain 
microplastic particles which may cause harm to the 
marine environment (DEFRA, 2017) 
United 
States 
July 2017 
(manufacture), 
January 2018 
(cosmetic product 
sale) 
Microbead-Free 
Waters Act of 2015 
Prohibits the manufacture and interstate commerce 
of cosmetic products with intentionally-added wash-
off plastic particles > 5 mm in diameter. Manufacture 
of microbeads banned from July 2017 and ban of the 
sale of cosmetic products containing microbeads from 
January 2018 (Microbead-Free Waters Act of 2015). 
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3.7.1 Significant legislation regulating the manufacture, sale and import of products 
containing plastic particles 
At the time of writing (early 2017), only the United States, Canada and New Zealand had 
legislated clear regulation of the manufacture, sale and import of cosmetic products 
containing plastic particles >5 mm in diameter (Table 6). Other nations including the United 
Kingdom, Taiwan, South Korea and France have proposed legislation (at the time of writing) 
which would take effect between late 2017 to mid 2018. Although individual U.S. states 
including California, Colorado and New York had previously implemented bans on the sale 
of cosmetic products containing plastic particles, the United States-wide congressional 
legislation H.R. 1321 (Microbead-free Water Act of 2015) was the first major regulatory 
decision on plastic microparticles. Much of the following regulation by other nations 
followed the template of H.R. 1321, which included an initial ban on the manufacture of 
plastic micropartles followed by a subsequent ban (6 months later) on the sale and import 
of cosmetic products containing plastic microparticles (Table 6).  At the time of writing, no 
European Union-wide legislation is proposed despite the governments of Austria, Belgium, 
Sweden, Luxembourg and the Netherlands calling for an EU-wide ban in 2014 (Council of the 
European Union, 2014).  
Despite regulatory decisions, as microplastics are also produced by degradation of 
larger plastic pieces (National Oceanic and Atmospheric Administration, 2016), such 
legislation is likely to not have a significant effect on the amount of microplastic particles in 
the environment for many hundreds of years. Research should focus on determining their 
possible environmental implications rather than mechanisms to reduce their prevalence. 
 
4.0 Conclusions and Direction for Research 
 
Contamination of water by pharmaceutical, personal care products and other emerging 
contaminants is unavoidable as long as their uses remain such an indispensable component 
of a modern and healthy society. Such contaminants are virtually ubiquitous in the aquatic 
environment and are rarely detected in some drinking waters (Jjemba, 2006; Silva et al., 
2011; Raghav et al., 2013; United States Geological Survey, 2016a). Currently, technology 
and techniques utilised in sewage/wastewater, and potentially drinking water, treatment 
are not complete barriers to these contaminants. While future research must focus on 
increasing PPCP/EC removal efficiencies in sewage treatment, complete removal prior to 
environmental introduction is likely not practical (Radjenovic et al., 2009; Hirani et al., 
2013).  
  Future study may focus on the elucidation of largely unknown breakdown products 
and their formation during sewage treatment, natural photochemical transformation and 
biological degradation. The potential environmental toxicity of such breakdown products 
should also be considered as some transformation products may be equally, if not more 
toxic than parent compounds (Boreen et al., 2003; Latch et al., 2003b; Ruggeri et al., 2013; 
Bergheim et al., 2014). Such investigation could be undertaken as suggested by Boreen et al. 
(2003) where biological assays are coupled with degradation study in such a way that 
adverse biological outcomes are assessed and compared before and after transformation of 
parent compounds without having to identify the breakdown products themselves. 
Subsequently, more detailed study could identify the specific chemical structures of 
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transformation products produced under study conditions which may mimic those observed 
in specific sewage treatment facilities. Such STW-specific conditions, when coupled with 
quantitative structural-activity relationship models and the abovementioned toxicity 
assessments may inform the creation of novel models for predicting the toxicity of 
transformation products under defined conditions. 
  Much remains to be elucidated regarding variables and conditions influencing the 
environmental fate and attenuation of PPCPs and other ECs. Some contaminants appear to 
bioaccumulate, preferentially bind to suspended solids or river sediment, volatilise, interact 
with other environmentally present components (plastics, heavy metals), and breakdown 
into unknown or poorly understood metabolites, each with potentially independent fates 
and behaviours. This concept particularly challenges the identification of contaminants 
present in the environment as some may only exclusively present in certain aquatic matrices 
leading to great uncertainty regarding where exactly to look (Patrolecco et al., 2006; Silva et 
al., 2011). Much research and classification is still needed to understand the environmental 
fate and metabolism of PPCP and other ECs, particularly when associating with media such 
as biofilms, micro-/nanoplastic particles and distribution between dissolved and less-
bioavailable bound fractions in water. Specific work focusing on the factors influencing the 
uptake of ionisable chemicals into aquatic organisms is warranted. 
 
Four overarching challenges are posed at present which present the need for continued and 
future, likely highly-interdisciplinary research:  
 
1) Identification of new environmentally present contaminants and both new and 
existing transformation products is particularly challenging as new drugs and 
replacements for regulatory limited compounds are continually being introduced to 
market and subsequently into the environment; 
 
2) Compounds used to replace those which are statutory/regulation-limited must be 
comprehensively studied to elucidate ultimate environmental fate and potential toxicity. 
Such research may focus on perfluorinated compounds of <6 carbon chains such as PFBS 
as well as plasticisers BPS, BPF and BPAF; 
 
3) The presence of antibiotics in the aquatic environment is thought to have a role in the 
development of antimicrobial resistance (see section 2.2). Study may most efficiently 
focus on the potential transfer mechanisms of antibiotic-resistant genes originating from 
bacteria within sewage treatment facilities and urban wastewater systems to bacteria in 
receiving surface waters and potential risk reduction using disinfection (e.g., UV) at STW 
facilities; and 
 
4) As regulation will likely not eliminate the presence of plastic particles in the 
environment for many thousands of years (as plastic does not degrade but simply 
fragments), specific research is warranted to determine the effects/rate of plastic 
fragmentation on potential particle toxicity (if any), ability to retain emerging 
contaminants (if any), uptake by organisms and distribution in the environment. 
  
 Since the late 1990s, significant progress has been made in the understanding of the 
sources, occurrence and fate of pharmaceuticals, personal care products and other 
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emerging contaminants. Regardless, this topic is likely to dominate emerging environmental 
chemistry for many years to come as our understanding of the field becomes deeper and 
ultimately more interdisciplinary. 
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pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP 
effluents and their receiving bodies in the Po Valley, Italy”, Science of the Total Environment, vol. 
438, pp. 15-25.  
American Dental Association 2016, “Oral Health Topics: ADA Statement on Bisphenol A and Dental 
Materials,” [online], available at <http://www.ada.org/en/member-center/oral-health-
topics/bisphenol-a> [Last accessed 18 April 2016] 
Arvaniti, O.S. and Stasinakis, A.S., 2015. Review on the occurrence, fate and removal of 
perfluorinated compounds during wastewater treatment. Science of the Total Environment, 524, 
pp.81-92. 
Baker, S.D., Wirth, M., Statkevich, P., Reidenberg, P., Alton, K., Sartorius, S.E., Dugan, M., Cutler, D., 
Batra, V., Grochow, L.B., Donehower, R.C. & Rowinsky, E.K., 1999, "Absorption, metabolism, and 
excretion of 14C-temozolomide following oral administration to patients with advanced cancer", 
Clinical cancer research: an official journal of the American Association for Cancer Research, vol. 
5, no. 2, pp. 309-317. 
Baquero, F., Martínez, J. & Cantón, R., 2008, "Antibiotics and antibiotic resistance in water 
environments", Current Opinion in Biotechnology, vol. 19, no. 3, pp. 260-265.  
Barnes, K.K., Kolpin, D.W., Meyer, M.T., Thurman, E.M., Furlong, E.T., Zaugg, S.D. & Barber, L.B., 
2002, Water-quality data for pharmaceuticals, hormones, and other organic wastewater 
contaminants in US streams, 1999-2000, US Department of the Interior, US Geological Survey. 
Barron, L., Nesterenko, E., Hart, K., Power, E., Quinn, B., Kelleher, B. & Paull, B., 2010, "Holistic 
visualisation of the multimodal transport and fate of twelve pharmaceuticals in biosolid enriched 
topsoils", Analytical and Bioanalytical Chemistry, vol. 397, no. 1, pp. 287-296. 
Barraza, L., 2013, "A new approach for regulating bisphenol A for the protection of the public's 
health," The Journal of Law, Medicine & Ethics, vol. 41, no. s1, pp. 9-12. 
Baumann, L., Knorr, S., Keiter, S., Rehberger, K., Volz, S., Schiller, V., and Braunbeck, T. (2014). 
Revers- ibility of endocrine disruption in zebrafish (Danio rerio) after discontinued exposure to 
the estrogen 17a-ethinylestradiol. Toxicology and Applied Pharmacology, 278(3), 230 237.  
Benotti, M.J. & Brownawell, B.J., 2009, "Microbial degradation of pharmaceuticals in estuarine and 
coastal seawater", Environmental Pollution, vol. 157, no. 3, pp. 994-1002. 
Bergh, C., Torgrip, R., Emenius, G., & Ostman, C., 2011, “Organophosphate and phthalate esters in 
air and settled dust – a multi-location indoor study”, Indoor Air, vol. 21, pp. 67–76.  
Bergheim, M., Gminski, R., Spangenberg, B., Dębiak, M., Bürkle, A., Mersch-Sundermann, V., 
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